Feedback / Questions
onilcamotide (RV001) - RhoVac
https://www.prnewswire.com/news-releases/another-clean-interim-safety-review-of-rhovacs-clinical-phase-iib-study-in-prostate-cancer-301440945.html
Dec 9, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next